Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
PF-04634817 (oral administration
po) treatment produces significant decreases in hepatic expression of mRNAs for SREBP-1
Morizumi S
The gels are soaked in dye and excess stain is then eluted with a solvent (“de-staining”)
decreased conditioned fear stress with low doses (4 and 20 mg/kg
Gefitinib impurity 2 Catalog No.:M31681-C PF-04634817 (oral administrationGefitinib impurity 2 is the impurity of Gefitinib. Gefitinib (ZD1839; HY 50895) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib selectively inhibits EGF stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF stimulated EGFR autophosphorylation in tumor cells. Gefitinib also induces autophagy. Gefitinib has antitumour activity. Product information CAS Number: 246512 44 7 Molecular
US$ 117.50
US$ 24.99
US$ 20.99
US$ 129.50
US$ 123.50
US$ 144.50
US$ 132.50
US$ 119.50
US$ 132.00
US$ 140.00
US$ 137.00
US$ 19.99